AACE Podcasts

Join AACE Past President and endocrinologist Dr. Susan Samson as she leads a compelling roundtable discussion highlighting the importance of the endocrine care team model. She is joined by nurse practitioner Dominique Uva, physician associate Sonia Bahroo, nurse scientist and diabetes educator Dr. Julia Blanchette, endocrine pharmacist Dr. Diana Isaacs, and nurse practitioner and clinical professor Dr. Chris Yedinak. Together, they explore how multidisciplinary care teams are essential to addressing the growing burden of endocrine diseases such as diabetes and thyroid disorders. Each expert shares how they collaborate across disciplines to improve access, provide patient support, and extend specialist care, especially in underserved communities. Tune in for practical insights, collaborative strategies, and a deeper look into how team-based care can elevate endocrine health outcomes.

In this episode, Dr. Jaime Almandoz, Associate Professor of Medicine at UT Southwestern, is joined by Dr. Robert F. Kushner, Professor of Medicine at Northwestern University and a leading authority in obesity medicine, to discuss the recent Lancet Diabetes & Endocrinology Commission report, “Definition and Diagnostic Criteria of Clinical Obesity.” The report introduces a new framework for defining clinical and preclinical obesity, aiming to move beyond the limitations of BMI. Dr. Kushner shares insights into the Commission's global consensus process and how the updated definitions can transform care, reduce weight stigma, and support more targeted treatment. Don't miss this timely conversation on the evolving future of obesity diagnosis and management.

Join 2025 Annual Meeting Chair, Cecilia Low Wang, MD, FACP, FACE, as she interviews Rachna Relwani, MD, Chair of the Environmental Endocrinology Topic Interest Group (TIG), and David C. Lieb, MD, FACP, FACE, Chair of the Artificial Intelligence and Clinical Endocrinology TIG. In this episode, you'll gain insight into how these TIGs are advancing critical conversations, fostering collaboration through AACE's new Facebook Groups, and preparing for engaging meetups at the AACE Annual Meeting in Orlando, May 15–17. Whether you're passionate about environmental health or curious about the role of AI in clinical practice, this episode offers a dynamic preview of what's ahead.

Join endocrine experts Lubaina S. Presswala, DO, FACOI, FACE; Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, FADCES; and Viral N. Shah, MD, FACE, as they explore the latest in continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems for managing diabetes. In this episode, they discuss the practical applications of diabetes technology, patient selection, shared decision-making, and considerations for device use in specific populations, including athletes and pregnant individuals. This conversation provides valuable insights to help clinicians navigate device options and enhance outcomes across diverse patient scenarios.

Join Dr. David Lieb as he moderates a discussion with Dr. Jaydira Del Rivero, Chair of the MEN1 Consensus Statement Task Force, and Dr. Michelle Lundholm, Methodology Fellow, about the recently released 2025 AACE Consensus Statement on the Management of Multiple Endocrine Neoplasia, Type 1 (MEN1).This episode covers:AACE's updated consensus statement methodology, including the new methodology fellow and patient representative rolesThe role of surgical and non-surgical management strategies for patients with different types of MEN1-related tumorsThe importance of patient values and preferences and risks/benefits of different screening modalities when determining appropriate screening frequencies for patientsCurrent gaps in the literature and future considerations for MEN1 research

Early detection and monitoring of Type 1 Diabetes (T1D) are crucial for improving patient outcomes and quality of life. Join clinical experts Lubaina S. Presswala, DO, FACOI, FACE; Jeff Unger, MD, FAAFP, FACE, DACD; and Javier Morales, MD, FACP, FACE, as they discuss the growing prevalence of T1D, the importance of autoantibody screening, the different stages of T1D, screening guidelines, patient counseling, and how early intervention can help delay progression and reduce complications. Support for this podcast is provided by Sanofi.

In this episode, join moderator Dr. David Lieb alongside esteemed panelists Dr. Shahnaz Sultan, Dr. Carol Peng, and Dr. Melanie Bird as they delve into the methodology behind the 2025 AACE Clinical Practice Guideline on Pharmacologic Management of Adults with Dyslipidemia.Discover insights into:Why AACE adopted the GRADE framework and its implications for guideline development.The critical role of systematic reviews in creating evidence-based recommendations.How evidence is assessed using the GRADE approach.Practical takeaways for clinicians when implementing GRADE-informed guidelines in patient care.Whether you're a seasoned practitioner or new to the field, this discussion offers valuable perspectives on the evolution of evidence-based guideline development and its impact on clinical practice.

Join Dr. David Lieb as he moderates an engaging discussion with Dr. Shailendra Patel, Chair of the Dyslipidemia Guideline Task Force, and Dr. Kathleen Wyne, Vice Chair, about the recently released 2025 AACE Clinical Practice Guideline on Pharmacologic Management of Adults with Dyslipidemia.This episode covers:What's new or different in this update compared to the 2017 guideline.Surprising insights revealed during the evidence assessments and how they shaped the recommendations.Key considerations for clinicians as they integrate these updated recommendations into practice.Gaps in the literature and opportunities for future research.Whether you're familiar with the previous guideline or new to this topic, this conversation provides a comprehensive overview of the latest advancements in dyslipidemia management.

Join endocrine expert Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, for a special AACE Podcast featuring her patient, Andree. Together, they explore Andree's personal journey with thyroid disease and how the AACE Journey for Patients With Thyroid Disease website has been an invaluable resource, offering clear and accessible tools to navigate her thyroid condition with confidence. Don't miss this inspiring discussion, brought to you with the support of AbbVie and Amgen Rare Disease.

Join endocrine experts Vin Tangpricha, MD, PhD, FACE, Editor-in-Chief of Endocrine Practice (EP) and Professor of Medicine at Emory University School of Medicine, and Rifka C. Schulman-Rosenbaum, MD, FACE, FACP, Director of Inpatient Diabetes at Long Island Jewish Medical Center, Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Northwell Health, and Chair Elect for the AACE 2025 Annual Meeting, as they discuss Dr. Schulman-Rosenbaum's EP article, “Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia.” Tune in as they explore the complexities of managing inpatient hyperglycemia, the risks of SGLT-2 inhibitors in hospitalized patients, and who might be good candidates for safer alternatives like DPP-4 inhibitors and insulin. Packed with valuable insights and practical strategies, this discussion is essential for optimizing hospital-based diabetes care. Read the full article in the April 2024 issue of EP here.

Join endocrine experts Vin Tangpricha, MD, PhD, FACE, Editor-in-Chief of Endocrine Practice (EP) and Professor of Medicine at Emory University School of Medicine, and Cecilia C. Low Wang, MD, FACE, FACP, Professor of Medicine and Medical Director for the Glucose Management Team at the University of Colorado, as they discuss Dr. Low Wang's impactful EP article titled "Safety and Efficacy of Insulins in Critically Ill Patients Receiving Continuous Enteral Nutrition." Tune in as they explore strategies for managing hyperglycemia and hypoglycemia in hospitalized patients on continuous tube feeds, evaluate insulin regimens such as 70/30 Q-8 hours and basal-bolus, examine differences in glycemia management for patients with and without diabetes, and discuss ways to optimize glycemic control. View the full article in the April 2024 issue of EP here.

Discover insights into the challenging landscape of Cushing syndrome, where adrenal variations require careful diagnostic and therapeutic strategies. In this podcast, Sina Jasim, MD, MPH, Editor-in-Chief of the AACE Clinical Reports (ACCR) and Associate Professor of Medicine at Washington University School of Medicine, leads a compelling discussion on two unique cases featured in the ACCR article, Histopathologic Differences Between Adrenocorticotropic Hormone–Dependent and Adrenocorticotropic Hormone–Independent Adrenal Hyperplasia Causing Cushing Syndrome. Authors, Amir H Hamrahian, MD, Endocrinologist, Associate Professor, and Medical Director of the Comprehensive Adrenal Center at Johns Hopkins University School of Medicine, and Ezra Baraban, MD, Assistant Professor of Pathology at Johns Hopkins University School of Medicine, explain the diagnostic challenges for each case, the decision-making process between medical and surgical approaches, and the critical role of pathology in guiding clinical care. Read the full case report in ACCR at https://www.aaceclinicalcasereports.com/article/S2376-0605(22)00066-9/fulltext.

Obesity is a complex, chronic disease of excessive or abnormally accumulated body fat that significantly increasing the risk of various medical conditions. As the most prevalent chronic disease in the United States—affecting 40% of the population—and impacting 1 in 8 people globally, finding reliable, clinically accurate, and patient-friendly information online can be challenging. To address this gap, AACE developed the “AACE Journey for Patients With Obesity,” a comprehensive resource designed to empower people with obesity to navigate their condition, treatment options, and wellness goals. In this episode, leading endocrinologists Elizabeth Bauer, MD, FACP; Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU; and Kenneth Izuora, MD, MBA, FACE, discuss the journey's development using the latest guidelines, including the integration of adiposity-based chronic disease (ABCD) terminology, which addresses the stigma associated with obesity. They also highlight the collaboration with the Obesity Action Coalition to ensure the resource is patient-centered and explain how both patients and health care professionals can utilize it to enhance care and improve outcomes. Support for this podcast was provided in part by Lilly and Boehringer Ingelheim.

Join Maria A. Mogollon, MSN, APRN, FNP-BC, a Diabetes and Obesity Nurse Practitioner and former Internal Medicine physician in Venezuela, and Jeff Unger, MD, FAAFP, FACE, DACD, Director, Unger Primary Care Concierge Medical Group, renowned Board-Certified Family Physician, Diabetologist, and co-author of the AACE 2021 Clinical Practice Guideline for the Use of Advanced Technology in the Management of Persons with Diabetes Mellitus, as they delve into crucial topics in diabetes technology. Key topics discussed include the benefits and cost-effectiveness of continuous glucose monitors (CGM) compared to traditional finger-stick methods, practical implementation into practice workflows, interpreting CGM data, and identifying ideal candidates for CGM use. Through case studies and practical examples, they address common concerns and barriers to CGM adoption, providing valuable insights for healthcare professionals on how to have effective conversations with patients and integrate CGM technology into patient care.

Join endocrine experts Ty Carroll, MD, Associate Professor of Medicine at the Medical College of Wisconsin, and Vin Tangpricha, MD, PhD, FACE, Editor-in-Chief of Endocrine Practice (EP) and Professor of Medicine at Emory University School of Medicine, as they delve into Dr. Carroll's groundbreaking EP article titled "Hormonal Contraceptive Use Is Associated With a Decreased Incidence of Hypothyroidism." Tune in as they discuss the study findings on the association between hormonal contraceptive use and reduced hypothyroidism risk, along with its limitations and implications for future research. View the full article in the Jan. 2024 issue of EP at https://www.endocrinepractice.org/article/S1530-891X(23)00715-2/abstract.

The frequency of hematospermia in transgender women is unknown, indicating a gap in current medical understanding. Join medical experts Tamar Reisman, MD, Clinical Endocrinologist at New York Presbyterian Weill Cornell Medical Center, and Sina Jasim, MD, MPH, ACCR Editor-in-Chief and Associate Professor of Medicine at Washington University School of Medicine, as they delve into a groundbreaking clinical case report titled "Hematospermia in a Transgender Woman with Evidence for Endometrial Tissue in the Prostate." Tune in as they discuss the highlights of the case, when to screen for endometriosis or ectopic Müllerian epithelial tissue growth in transgender women undergoing feminizing gender-affirming hormone therapy, and how to address challenges and barriers to patient care. View the full report in the Jan. 2024 issue of ACCR at https://doi.org/10.1016/j.aace.2024.01.006.

Thyroid disease affects approximately 20 million Americans, leading many patients to turn to the internet for answers. However, amidst the vast array of information available online, distinguishing accurate information can be challenging. Recognizing this necessity, the endocrine experts at AACE have developed "The Journey For Patients With Thyroid Disease," an innovative resource devoted to educating and empowering individuals with thyroid disease to navigate their condition, treatment plan, and wellness goals. In this podcast, endocrine experts Alex Tessnow, MD, ECNU, FACE, Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, and Kenneth Izuora, MD, MBA, FACE, delve into the development, significance, and accessibility of this patient resource. Key topics discussed include the meticulous crafting of the journey into a meta-map using the latest AACE guidelines, the importance of providing patients with resources beyond the clinical setting, and how this resource serves as an invaluable tool for both patients and clinicians, providing timely updates on the latest clinical advancements for thyroid care. Support for this podcast was provided in part by AbbVie.

Join endocrine expert Janet B. McGill, MD, MA, FACE, FACP, Professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University School of Medicine, and moderator Sina Jasim, MD, MPH, ACCR Editor-in-Chief, Associate Professor of Medicine, and Endocrine Neoplasia Specialist at Washington University School of Medicine, as they discuss diabetes clinical case reports from the July/August 2023 issue of ACCR. Dr. McGill presents two key cases, MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome, — a case of a young woman whose monogenic diabetes was diagnosed after a pathogenic ~1.8 Mb loss of 17q12 was found on the chromosomal microarray of her serous ovarian carcinoma and identifying a disease association not previously reported. The second case was on the maturity-onset of diabetes of the young (MODY), ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent, — a case of type 1 diabetes diagnoses during adolescence, and how the patient was treated with intensive insulin therapy for 17 years before genetic testing showed a pathogenic mutation of the ABCC8 gene. Access the key teaching points and view the full cases of MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome at: https://www.aaceclinicalcasereports.com/article/S2376-0605(23)00093-7/fulltext and ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent at: https://www.aaceclinicalcasereports.com/article/S2376-0605(23)00086-X/fulltext

Parathyroid cysts (PC) are a rare cause of neck masses, with an ectopic intrathyroidal location being even more rare. Join endocrine experts Victor J. Bernet, MD, FACE, FACP, Director, Endocrinology, Diabetes and Metabolism Fellowship Program at the Mayo Clinic in Florida, and Sina Jasim,  MD, MPH, ACCR Editor-In-Chief, Associate Professor of Medicine, and Endocrine Neoplasia Specialist at Washington University School of Medicine, as they discuss the clinical case report, A Middle-aged Woman With Recurrent Intrathyroidal Parathyroid Cyst Treated With Ethanol Sclerotherapy, which presents a case of a recurrent intrathyroidal cyst successfully treated with ethanol sclerotherapy. Key topics discussed include the sclerosis efficacy in orthotopically positioned PCs, how ethanol sclerotherapy is an effective treatment option for recurrent intrathyroidal PCs, and important teaching points of this case. Visit https://www.aaceclinicalcasereports.com/article/S2376-0605(23)00131-1/fulltext to read the full AACE Clinical Case Report.

Join clinical experts David Lieb, MD, FACE, Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, and Vin Tangpricha, MD, PhD, FACE, as they discuss the 2022 AACE diabetes guideline updates and address the issue, “How Should Hypoglycemia Be Managed?” Key topics include how to put the guideline into practice particularly in primary care settings, how to characterize which people with diabetes should be prescribed glucagon to manage low blood sugar levels, and how to incorporate ready-to-use glucagon into hypoglycemia treatment plans for people with diabetes. Support for this podcast is provided by Xeris Pharmaceuticals, Inc.

Minimally invasive procedures are now more widely used for benign and some low-risk cancerous thyroid tumors. In certain cases of papillary thyroid microcarcinomas; and if those are positioned in a favorable location, Radiofrequency Ablation (RFA) offers a less invasive treatment option compared to traditional surgical approaches. Listen to Leonardo Guimarães Rangel, MD, Head and Neck Surgeon in Rio de Janeiro, Brazil, and international expert in minimally invasive procedures in thyroid tumors, present his Visual Vignette on Radiofrequency Ablation of Papillary Thyroid Microcarcinomas,  moderated by Sina Jasim, MD, MPH, Associate Professor of Medicine, and Endocrine Neoplasia Specialist at Washington University School of Medicine. Key topics include procedure safety, determining the right patient and nodule candidate, follow-up care, challenges, and future outcomes. Visit https://www.aaceclinicalcasereports.com/article/S2376-0605(22)00010-4/fulltext to view and read the full AACE Visual Vignette.

Join endocrine experts Ricardo Correa, MD, FACP, FACMQ, FAPCR, FACE; Rajesh Garg, MD, PhD; and Geetha Gopalakrishnan, MD, FACE, as they share valuable tips and success stories on how to talk to patients with diabetes about the importance of vaccinations in diabetes management. Key topics include strategies for addressing barriers in workflows, differences in cultural norms and vaccine hesitancy. AACE endocrine experts share available patient resources along with a wealth of information aimed at enhancing your interactions with patients. 

AACE has revised its policies and adopted a new methodology for guideline and consensus statement development to support the mission to elevate the practice of clinical endocrinology to improve patient care. Join endocrine experts Ricardo Correa, MD, FACP, FACMQ, FAPCR, FACE, Joanna Miragaya, MD, PhD, FACE, and Vin Tangpricha, MD, PhD, FACE, as they dive into the 2023 protocol updates. Key topics include updates to methodology, processes, and policies. Visit https://www.endocrinepractice.org/article/S1530-891X(23)00032-0/fulltext to view the protocol in the May 2023 issue of Endocrine Practice.

Wolfram syndrome (WS) is a rare genetic disorder in which patients develop early-onset diabetes mellitus (DM), optic nerve atrophy, and neurodegeneration, which has no specific treatment available. Listen to endocrine experts Fumihiko Urano, MD, PhD. Samuel E. Schechter Professor of Medicine at Washington University School of Medicine, and Sina Jasim, MD, MPH, Associate Professor of Medicine at Washington University School of Medicine, discuss a new clinical case report on two patients with Wolfram syndrome who were initially diagnosed with type 1 diabetes but were negative for islet autoantibodies. Key topics include the importance of distinguishing between Wolfram syndrome and type 1 diabetes, the significance of the homozygous vs. compound heterozygous pathogenic variants in WFS1 gene, how the management and treatment for Wolfram syndrome differs from that of type 1 diabetes, the current status of therapeutic interventions, and much more. Visit https://doi.org/10.1016/j.aace.2022.01.001 to read the full AACE Clinical Case Report.

Join endocrine experts Karl Nadolsky, DO, DABOM, and Vin Tangpricha, MD, PhD, FACE, as they discuss the 2023 AACE Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity. Key topics include defining weight stigma, bias, and internalized weight bias (IWB), empowering patients and our global society to address obesity as a chronic disease, intervention recommendations using the 5A model, and much more. Visit https://www.endocrinepractice.org/article/S1530-891X(23)00335-X/fulltext to view the consensus statement in the June 2023 issue of Endocrine Practice.

Join endocrine experts Irl Hirsch, MD, Susan L. Samson, M.D., Ph.D., FRCPC, FACE, and Vin Tangpricha, MD, PhD, FACE, as they discuss the latest updates to AACE's 2023 diabetes algorithm, which provides concise guidance to assist health care professionals in clinical decision-making for the management of Type 2 diabetes (T2D). Learn how to leverage the algorithm to improve patient care, how someone's risk for hypoglycemia impacts their individual target, when to use a complications-centric and glucose-centric approach to choosing first-line therapy for glycemic control, and much more. Visit https://doi.org/10.1016/j.eprac.2023.02.001 to view the full algorithm in the May 2023 issue of Endocrine Practice.

Nonalcoholic fatty liver disease (NAFLD) is a major health problem that is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Join endocrine experts Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, and Sangeeta Kashyap MD, Assistant Chief of Clinical Affairs at New York-Presbyterian/Weill Cornell Medical Center, to learn how to diagnose and manage NAFLD and NASH in primary care and endocrinology clinical settings. Key topics include screening for NAFLD/NASH, and the latest management recommendations including supplements, medications, bariatric surgery, and more.

In this podcast endocrine expert David C. Lieb, MD, FACP, FACE, interviews our AACE 2023 award-winning plenary speakers, Elizabeth N. Pearce, MD, MSc, FACE, Irl Hirsch, MD, and Richard J. Auchus, MD, PhD, FACE, about the latest advancements in thyroid disease, diabetes, and adrenal disease. Key topics include iodine deficiency, adjusting thyroid medication doses, the future of insulin therapy, GMI compared to A1C levels, screening for primary aldosteronism, Cushing's syndrome, adrenal steroid profiling, and more. 

There is varying knowledge among members of the endocrine care team about the vaccines AACE recommends for persons with diabetes that are included in the updated 2022 AACE Diabetes Guideline. In this podcast endocrine expert Vin Tangpricha, MD, PhD, interviews internationally known clinician, epidemiologist, and Interim Dean of Emory University School of Medicine, Carlos del Rio, MD, about the importance of vaccines, how vaccines are made, developed, and approved, and how to use this information to address patients' questions or hesitancy towards vaccines.

Join endocrine experts S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, Susan L. Samson, MD, PhD, FRCPC, FACE, and Vin Tangpricha, MD, FACE, as they discuss the 2022 AACE diabetes clinical practice guideline featuring 170 updated and new evidence-based recommendations for the care and management of people with or at risk for diabetes mellitus. Key topics include how to use the guideline in your practice, new content developed on hypoglycemia, secondary diabetes approaches, supplements, social determinants of health, and more. Plus, get an inside sneak peek into the development of a diabetes care algorithm coming soon. Visit https://www.endocrinepractice.org/article/S1530-891X(22)00576-6/fulltext to view the full guideline published in the October 2022 issue of Endocrine Practice.

Listen to endocrine experts, Vinni Makin, MD, Joumana Chaiban, MD, and Ricardo Correa, MD, share their personal experiences about how they obtained a Visa as international medical graduates and transitioned to practicing medicine in the United States. Key topics include Visa requirements, how to apply for a Visa, and the benefits of a mentorship program once you transition to the U.S.

For persons with diabetes, vaccinations have been shown to help them from contracting and experiencing more severe outcomes from preventable illnesses, such as influenza and Covid-19.It is important for the endocrine care team to learn practical strategies for increasing vaccination rates for their patients with diabetes. Join endocrine experts Geetha Gopalakrishnan, MD, FACE and David C. Lieb, MD, FACE as they share their perspectives and experiences on advancing immunizations by using the CDC's Standards for Adult Immunization Practice and working to build a practice culture of vaccine confidence. Visit www.AACE.com/immunization for additional education and resources.

Adrenal insufficiency is a life-threatening condition but diagnosis is typically delayed. The initial presentation is often non-specific and physician awareness must be improved to avoid adrenal crisis. Join endocrine experts Shobana Athimulam, MD, Clinical Assistant Professor, Division of Endocrinology, Bone and Mineral Disorders in Henry Ford Health, Detroit, Michigan, and Lucinda Gruber, MD, Assistant Professor, Division of Endocrinology, Diabetes, Metabolism and Nutrition at Mayo Clinic in Rochester, Minnesota, as they discuss the etiology and clinical presentation of patients with adrenal insufficiency, challenges in making the diagnosis, role of dynamic testing and management of special patient populations.

Nonalcoholic fatty liver disease (NAFLD) is a major public health problem that will only worsen in the future, as it is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Given this link, endocrinologists and primary care physicians are in an ideal position to identify persons at risk to prevent the development of cirrhosis and comorbidities. Join endocrine expert Vin Tangpricha, M.D., Ph.D., as he interviews AACE Co-Chairs, guideline task force experts, Kenneth Cusi, MD, FACP, FACE, and Scott D. Isaacs, MD, FACP, FACE, about the newly released 2022 clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease, published in the May 2022 issue of Endocrine Practice (https://www.endocrinepractice.org/article/S1530-891X(22)00090-8/fulltext).

Having a high level of triglycerides in your blood can increase your risk of heart disease. Join endocrine experts Eliot A. Brinton, MD, FAHA, FNLA, FACE, President of Utah Lipid Center, and Past President, of the American Board of Clinical Lipidology, and Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, as they discuss the clinical management of Hypertriglyceridemia (HTG) for cardiovascular disease prevention.

The landmark Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT®) was a global outcomes study designed to assess the cardioprotective efficacy and safety of VASCEPA® (icosapent ethyl) as an add-on to statin therapy in reducing major cardiovascular (CV) events in a high-risk patient population. Join endocrine experts Eliot A. Brinton, MD, FAHA, FNLA, FACE, President of Utah Lipid Center, and Past President, of the American Board of Clinical Lipidology, and Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, to learn about the results of the REDUCE-IT® trial and new developments in CV prevention.

Minimally invasive thyroid techniques are effective and safe when performed by experienced centers. While surgery and radioiodine treatment remain the conventional and established treatments for nodular goiters, new image-guided minimally invasive approaches appear safe and effective alternatives to treat symptomatic or enlarging thyroid masses. Join endocrine experts Vin Tangpricha, M.D., Ph.D., Professor of Medicine at Emory University School of Medicine, as he interviews Sina Jasim, MD, MPH, Associate Professor of Medicine at Washington University in St. Louis, about nonsurgical minimally invasive approaches to managing thyroid nodules/malignancy, published in the April 2022 issue of Endocrine Practice (https://www.endocrinepractice.org/article/S1530-891X(22)00063-5/fulltext)

Many environmental factors have been found to influence cardiovascular disease (CVD) risk, progression, and severity. Join Sanjay Rajagopalan, MD, FACC, FAHA, Chief of Cardiovascular Medicine at the University Hospitals, Harrington Heart & Vascular Institute, Director of Cardiovascular Research Institute at Herman K. Hellerstein MD, Professor of Cardiovascular Research, and Professor of the Department of Internal Medicine at Case Western Reserve University, as he is interviewed by Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, Vice-Chair at UH System Clinical Affairs, Department of Medicine, Medical Director of the Diabetes & Obesity Center at Mary B. Lee Chair in Adult Endocrinology, University Hospital Cleveland Medical Center, and Chair of the AACE Disease State Network Lipids & Cardiovascular Health. Dr. Rajagopalan and Dr. Hatipoglu discuss components of the environment that play an important role in health besides general lifestyle factors, including social, economic, and chemical pollutants.

Join endocrine experts Joshua Safer, MD, FACE, FACP, and Vin Tangpricha, MD, PhD, FACE, as they present AACE's Position Statement: Transgender and Gender Diverse Patients and the Endocrine Community. Topics discussed include the four statements released by AACE, evidence-based guidelines that support endocrine care of transgender and gender diverse patients, and more.

Cardiovascular disease is the leading cause of death among women. Join experts Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, and Leslie Cho, MD, Professor of Medicine at Cleveland Clinic Lerner School of Medicine Case Western Reserve Medical School, Section Head of Preventive Cardiology & Rehabilitation, and Director of the Cleveland Clinic's Women's Cardiovascular Center, as they discuss common cardiovascular risk factors for women. Topics include, how to adequately assess lifetime risks for cardiovascular disease, risks from pregnancy, menopause, an autoimmune disease, and more.

In this podcast, endocrine experts, Michael T McDermott MD, Professor of Medicine, Director of the Endocrinology and Diabetes Practice at the University of Colorado Hospital, and Jane EB Reusch MD, Professor of Medicine-Endocrinology/Metabolism/Diabetes at the University of Colorado SOM and Rocky Mountain Regional VA Associate Director Ludeman Family Center for Women's Health Research, join moderator Georgia Davis, MD, Assistant Professor of Medicine at Emory University School of Medicine and Grady Memorial Hospital, to discuss the different aspects of diabetes remission and recent consensus guidelines, including how it's defined, achieved, and maintained.

As imaging techniques have improved and become more commonly used, health care professionals are finding more adrenal incidentalomas. Join endocrine experts Diane Donegan, MD, Chair, AACE Disease State Network Pituitary, Gonadal, Adrenal, & Neuroendocrine, and Assistant Professor of Clinical Medicine at Indiana School of Medicine, and Irina Bancos, MD, AACE Disease State Network Pituitary, Gonadal, Adrenal, & Neuroendocrine expert, and Associate Professor of Medicine and Adrenal Endocrinologist at the Mayo Clinic, as they discuss several interesting adrenal case studies and recommendations for clinical management of patients with adrenal incidentalomas.

Continuous glucose monitoring (CGM) technology allows patients to track their blood sugar levels over time. In this podcast, Endocrinologist Cheryl R. Rosenfeld, DO, FACE, FACP, FSVM, ECNU, and Internal Medicine Specialist Angela Cavanna, DO, discuss the benefits of CGM and different scenarios when you may want to refer a patient to an endocrinologist. 

Nonnutritive sweeteners (NNS) have been widely implemented as replacements for naturally occurring sugars in a wide array of foods, beverages, and non-consumables for the sake of reducing calories. However, are artificial sweeteners the solution or the problem? Join endocrine experts Elena A Christofides, MD, FACE, and Karl Nadolsky, DO FACE as they debate the pros and cons of artificial sweeteners with moderator Vin Tangpricha, MD, PhD.

As the COVID-19 vaccine rollout continues, there are some patients that remain hesitant about receiving a vaccination. Join endocrine experts Vin Tangpricha, MD, PhD, FACE, and Geetha Gopalakrishnan, MD, FACE, as they address how to approach a conversation about vaccine hesitancy with patients. Key discussion points include information for patients with diabetes or obesity, vitamin D recommendations, answers to commonly asked Covid-19 vaccination questions and more.  

Listen to AACE Co-Chairs, guideline task force experts, George Grunberger, MD, FACP, MACE, and Jennifer Sherr, MD, PhD, explain the newly released clinical practice guideline: Use of Advanced Technology in Management of Persons with Diabetes Mellitus, with moderator Vin Tangpricha, MD, PhD. The new guideline provides recommendations based on scientific evidence for health care professionals about the safe and effective use of advanced diabetes technology. Tune in to learn about key metrics for Continuous Glucose Monitoring (CGM), recommendations for continuous subcutaneous insulin infusion via insulin pumps, what health care professionals need to know in terms of safety, key takeaways, and much more.

Check out a sneak peek of what to expect at our 2021 Annual Meeting. David C. Lieb, MD, FACE, FACP, Chair of AACE Education Oversight Committee, interviewed Elizabeth N. Pearce, MD, MSc, FACE, Chair of the Annual Meeting Planning Committee, and Paul Markowski, Chief Executive Officer at AACE, about the upcoming 2021 Annual Meeting. Get the inside scoop about the keynote session, release of the new advanced diabetes technology guideline, exciting interactive sessions, unique patient symposiums, AACE strategic priorities, and much more!

In this podcast, Dr. Matthew Levine, practicing endocrinologist and the Endocrinology Fellowship Program Director at Scripps Clinic in San Diego, California, speaks with Dr. Mike Tuttle, acting chief of endocrinology at Memorial Sloan Kettering Cancer Center about the decision making process a practicing endocrinologist may face when managing patients with thyroid cancer.

In this podcast, Dr. Ann Kearns, an adult endocrinologist specializing in bone and calcium disorders from the Mayo Clinic in Rochester, MN speaks with Dr. Domingo Perez, about how endocrine therapy plays a role in postmenopausal breast cancer and treatment options for patients. Dr. Perez is a trained oncologist currently in an advanced breast cancer fellowship, at the Mayo Clinic in Rochester, MN.

In this podcast, Dr. Vijay Shivaswamy, endocrinologist at the University of Nebraska, and Dr. Cyrus Desouza, Chief of Endocrinology at the University of Nebraska discuss the effects of type 2 diabetes medications on cardiovascular risk reduction.

In this podcast, Dr. Jeffrey Freeman, Professor of Internal Medicine and Chairman of Division of Endocrinology at Philadelphia College of Osteopathic Medicine, and Dr. Cheryl Rosenfeld, Clinical Associate Professor of Medicine, Touro College of Osteopathic Medicine, Endocrinology Subspecialty Education Coordinator for the Prime Health Consortium Internal Medicine Residency Program, and in private practice with North Jersey Endocrine Consultants, discuss different types of combination therapy and the various treatment barriers to care they can present.